Audio poster

Risk mitigation strategy for concizumab clinical trials after pause due to non-fatal thrombotic events

Author
Seremetis S, Cepo K, Skovgaard Rasmussen J, Rose TH, Tamer S, Porstmann T, Haaning J
Citation
Stephanie Valer Seremetis, Katarina Cepo, Josephine Skovgaard Rasmussen, Trine Høyer Rose, Søren Tamer, Thomas Porstmann, Jesper Haaning; Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-Fatal Thrombotic Events. Blood 2020; 136 (Supplement 1): 40. doi: https://doi.org/10.1182/blood-2020-139563
Date of Publication

This website is intended
for healthcare professionals (HCPs)
outside of the U.S.

Take me to www.novonordisk.com